These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 38393642
1. Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents. Guo Y, Chen B, Guo J, Jiang P, Wang J, Sun W. Pharm Biol; 2024 Dec; 62(1):233-249. PubMed ID: 38393642 [Abstract] [Full Text] [Related]
2. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents. Wang ZZ, Sun WX, Wang X, Zhang YH, Qiu HY, Qi JL, Pang YJ, Lu GH, Wang XM, Yu FG, Yang YH. Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286 [Abstract] [Full Text] [Related]
3. The ester derivatives obtained by C-ring modification of podophyllotoxin induce apoptosis and inhibited proliferation in PC-3M cells via down-regulation of PI3K/Akt signaling pathway. Zhao Y, Li D, Wei M, Du R, Yan Z. Bioorg Med Chem Lett; 2021 Aug 15; 46():128174. PubMed ID: 34098082 [Abstract] [Full Text] [Related]
4. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Kamal A, Srinivasa Reddy T, Polepalli S, Shalini N, Reddy VG, Subba Rao AV, Jain N, Shankaraiah N. Bioorg Med Chem; 2014 Oct 01; 22(19):5466-75. PubMed ID: 25131956 [Abstract] [Full Text] [Related]
5. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y, Wei D, Zhao Y, Cheng W, Lu Y, Ma Y, Li X, Han C, Wei Y, Cao H, Zhao C. Bioorg Med Chem; 2012 Nov 01; 20(21):6285-95. PubMed ID: 23022053 [Abstract] [Full Text] [Related]
7. Novel hybrids of podophyllotoxin and formononetin inhibit the growth, migration and invasion of lung cancer cells. Yang C, Xie Q, Zeng X, Tao N, Xu Y, Chen Y, Wang J, Zhang L. Bioorg Chem; 2019 Apr 01; 85():445-454. PubMed ID: 30776555 [Abstract] [Full Text] [Related]
9. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, Srivastava AK. Eur J Med Chem; 2015 Jan 07; 89():128-37. PubMed ID: 25462233 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS, Tabeshpour J, Mirzaei S, Golmakaniyoon S, Tayarani-Najaran Z, Ghasemi A, Ghodsi R. Arch Pharm (Weinheim); 2019 Jun 07; 352(6):e1800307. PubMed ID: 31012156 [Abstract] [Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition. Li SS, Chen JJ, Zhang MM, Wang WX, Zhang WY, Ma C. Eur J Med Chem; 2024 May 05; 271():116425. PubMed ID: 38636129 [Abstract] [Full Text] [Related]
12. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R. Bioorg Chem; 2021 Jul 05; 112():104904. PubMed ID: 33933802 [Abstract] [Full Text] [Related]
13. Synthesis of a terphenyl substituted 4-aza-2,3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerization and apoptosis inducers. Kamal A, Tamboli JR, Nayak VL, Adil SF, Vishnuvardhan MV, Ramakrishna S. Bioorg Med Chem; 2014 May 01; 22(9):2714-23. PubMed ID: 24721832 [Abstract] [Full Text] [Related]
14. Modified Podophyllotoxin Phenoxyacetamide Phenylacetate Derivatives: Tubulin/AKT1 Dual-Targeting and Potential Anticancer Agents for Human NSCLC. Lin H, Ai D, Liu Q, Wang X, Gao J, Chen Q, Ruan L, Tao Y, Gao J, Wang L. J Nat Prod; 2023 Jul 28; 86(7):1844-1854. PubMed ID: 37395092 [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of benzo[b]furo[3,4-e][1,4]diazepin-1-one derivatives as anti-cancer agents. Malayeri SO, Tayarani-Najaran Z, Behbahani FS, Rashidi R, Delpazir S, Ghodsi R. Bioorg Chem; 2018 Oct 28; 80():631-638. PubMed ID: 30041139 [Abstract] [Full Text] [Related]
17. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization. Ma Y, Fang S, Li H, Han C, Lu Y, Zhao Y, Liu Y, Zhao C. Chem Biol Drug Des; 2013 Jul 28; 82(1):12-21. PubMed ID: 23786349 [Abstract] [Full Text] [Related]
18. Discovery of novel 2-substituted 2, 3-dihydroquinazolin-4(1H)-one derivatives as tubulin polymerization inhibitors for anticancer therapy: The in vitro and in vivo biological evaluation. Shi C, Yang B, He Z, Yang J, Li L, Song J, Xu S, Song W, Yang J. Eur J Med Chem; 2024 Nov 05; 277():116766. PubMed ID: 39163776 [Abstract] [Full Text] [Related]
19. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation. Han HW, Lin HY, He DL, Ren Y, Sun WX, Liang L, Du MH, Li DC, Chu YC, Yang MK, Wang XM, Yang YH. Chem Biodivers; 2018 Nov 05; 15(11):e1800289. PubMed ID: 30194898 [Abstract] [Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Yan XY, Leng JF, Chen TT, Zhao YJ, Kong LY, Yin Y. Eur J Med Chem; 2022 Jul 05; 237():114372. PubMed ID: 35447432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]